This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...